Skip to main content
SpringerLink
Log in

Critical Ischemia in Patients with Raynaud’s Phenomenon

  • Chapter
  • First Online:
Critical Limb Ischemia

  • 2446 Accesses

Abstract

Raynaud’s phenomenon (RP) is an episodic phenomenon in which the skin of the extremities undergoes a classical color change of white (the physiological basis for which is ischemia), blue (cyanosis), and red (hyperemia). The condition may be associated with significant discomfort and pain (Block and Sequeira, Lancet 357:2042–2048, 2001; Wigley, N Engl J Med 347:1001–1008, 2002). RP is usually idiopathic (primary RP), but may occur due to a driving etiology (secondary RP). Primary RP does not progress to digital ulceration or critical ischemia. Classification criteria for primary RP have been proposed and are widely used by clinicians (LeRoy and Medsger, Clin Exp Rheumatol 10:485–488, 1992; Maverakis et al., J Autoimmun 48–49:60–65, 2014). There is a wide range of causes of secondary RP, which may (albeit rarely) progress to critical digital ischemia with potential gangrenous progression requiring amputation. The distinction between primary and secondary RP is important as both the prognosis and management may differ significantly. The aim of this chapter is to describe the background, clinical evaluation, and treatment of the patient with RP who then presents with critical digital ischemia. Most of our review applies especially to patients with systemic sclerosis (SSc) because this is where the (limited) evidence base is the strongest.

The first section of the chapter deals with general principles of assessment and treatment, initially in the patient in whom the cause of secondary RP is unknown, and then in the patient with a known diagnosis of SSc. Although critical ischemia is a relatively rare complication of RP, nonetheless a significant proportion of affected patients require surgery: the surgical approach to management is described in the second section.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Block JA, Sequeira W. Raynaud’s phenomenon. Lancet. 2001;357(9273):2042–8.

    Article  CAS  PubMed  Google Scholar 

  2. Wigley FM. Clinical practice. Raynaud’s Phenomenon. N Engl J Med. 2002;347:1001–8.

    Article  PubMed  Google Scholar 

  3. LeRoy E, Medsger TA. Raynaud’s phenomenon: a proposal for classification. Clin Exp Rheumatol. 1992;10:485–8.

    CAS  PubMed  Google Scholar 

  4. Maverakis E, Patel F, Kronenberg DG, et al. International consensus criteria for the diagnosis of Raynaud’s phenomenon. J Autoimmun. 2014;48–49:60–5.

    Article  PubMed  Google Scholar 

  5. Nihtyanova SI, Brough GM, Black CM, Denton CP. Clinical burden of digital vasculopathy in limited and diffuse cutaneous systemic sclerosis. Ann Rheum Dis. 2008;67(1):120–3.

    Article  CAS  PubMed  Google Scholar 

  6. Poszepczynska-Guigné E, Viguier M, Chosidow O, Orcel B, Emmerich J, Dubertret L. Paraneoplastic acral vascular syndrome: epidemiologic features, clinical manifestations, and disease sequelae. J Am Acad Dermatol. 2002;47(1):47–52.

    Article  PubMed  Google Scholar 

  7. Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006;4(2):295–306.

    Article  CAS  PubMed  Google Scholar 

  8. Kim JS, Kim J, Choi D, et al. Efficacy of high-dose atorvastatin loading before primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: the STATIN STEMI trial. JACC Cardiovasc Interv. 2010;3:332–9.

    Article  PubMed  Google Scholar 

  9. Gabrielli A, Avvedimento EV, Krieg T. Scleroderma. N Engl J Med. 2009;360(19):1989–2003.

    Article  CAS  PubMed  Google Scholar 

  10. Katsumoto TR, Whitfield ML, Connolly MK. The pathogenesis of systemic sclerosis. Annu Rev Pathol. 2011;6:509–37.

    Article  CAS  PubMed  Google Scholar 

  11. Matucci-Cerinic M, Kahaleh B, Wigley FM. Review: evidence that systemic sclerosis is a vascular disease. Arthritis Rheum. 2013;65:1953–62.

    Article  CAS  PubMed  Google Scholar 

  12. Ho M, Veale D, Eastmond C, Nuki G, Belch J. Macrovascular disease and systemic sclerosis. Ann Rheum Dis. 2000;59(1):39–43.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Man A, Zhu Y, Zhang Y, et al. The risk of cardiovascular disease in systemic sclerosis: a population-based cohort study. Ann Rheum Dis. 2013;72:1188–93.

    Article  PubMed  Google Scholar 

  14. Hasegawa M, Nagai Y, Tamura A, Ishikawa O. Arteriographic evaluation of vascular changes of the extremities in patients with systemic sclerosis. Br J Dermatol. 2006;155(6):1159–64.

    Article  CAS  PubMed  Google Scholar 

  15. Allanore Y, Seror R, Chevrot A, Kahan A, Drapé JL. Hand vascular involvement assessed by magnetic resonance angiography in systemic sclerosis. Arthritis Rheum. 2007;56(8):2747–54.

    Article  CAS  PubMed  Google Scholar 

  16. Taylor MH, McFadden JA, Bolster MB, Silver RM. Ulnar artery involvement in systemic sclerosis (scleroderma). J Rheumatol. 2002;29(1):102–6.

    CAS  PubMed  Google Scholar 

  17. Park JH, Sung YK, Bae SC, Song SY, Seo HS, Jun JB. Ulnar artery vasculopathy in systemic sclerosis. Rheumatol Int. 2009;29(9):1081–6.

    Article  PubMed  Google Scholar 

  18. Frerix M, Stegbauer J, Dragun D, Kreuter A, Weiner SM. Ulnar artery occlusion is predictive of digital ulcers in SSc: a duplex sonography study. Rheumatology (Oxford). 2012;51(4):735–42.

    Article  Google Scholar 

  19. Matucci-Cerinic M, Denton CP, Furst DE, Mayes MD, Hsu VM, Carpentier P, et al. Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial. Ann Rheum Dis. 2011;70(1):32–8.

    Article  CAS  PubMed  Google Scholar 

  20. Badesch DB, Hill NS, Burgess G, et al. Sildenafil for pulmonary arterial hypertension associated with connective tissue disease. J Rheumatol. 2007;34(12):2417–22.

    PubMed  Google Scholar 

  21. Pulido T, Adzerikho I, Channick RN, et al. Macitentan and morbidity and mortality in pulmonary arterial hypertension. N Engl J Med. 2013;369(9):809–18.

    Article  CAS  PubMed  Google Scholar 

  22. van den Hoogen F, Khanna D, Fransen J, et al. 2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative. Ann Rheum Dis. 2013;72:1747–55.

    Article  PubMed  Google Scholar 

  23. van den Hoogen F, Khanna D, Fransen J, et al. 2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative. Arthritis Rheum. 2013;65:2737–47.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Wigley FM, Wise RA, Miller R, Needleman BW, Spence RJ. Anti-centromere antibody as a predictor of digital ischemic loss in patients with systemic sclerosis. Arthritis Rheum. 1992;35(6):688–93.

    Article  CAS  PubMed  Google Scholar 

  25. Herrick AL, Heaney M, Hollis S, Jayson MIV. Anti-cardiolipin, anti-centromere and anti-Scl-70 antibodies in patients with systemic sclerosis and severe digital ischaemia. Ann Rheum Dis. 1994;53(8):540–2.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Boin F, Franchini S, Colantuoni E, Rosen A, Wigley FM, Casciola-Rosen L. Independent association of anti-β2-glycoprotein I antibodies with macrovascular disease and mortality in scleroderma patients. Arthritis Rheum. 2009;60(8):2480–9.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Harrison BJ, Silman AJ, Hider SL, Herrick AL. Cigarette smoking as a significant risk factor for digital vascular disease in patients with systemic sclerosis. Arthritis Rheum. 2002;46(12):3312–6.

    Article  PubMed  Google Scholar 

  28. Higgins JP, McClinton MA. Vascular insufficiency of the upper extremity. J Hand Surg [Am]. 2010;35(9):1545–53.

    Article  Google Scholar 

  29. Zhou AY, Muir L, Harris J, Herrick AL. The impact of magnetic resonance imaging in early diagnosis of hand osteomyelitis in patients with systemic sclerosis. Clin Exp Rheumatol. 2014;32(6 Suppl 86):232.

    Google Scholar 

  30. Iorio ML, Masden DL, Higgins JP. Botulinum toxin A treatment of Raynaud’s phenomenon: a review. Semin Arthritis Rheum. 2012;41(4):599–603.

    Article  CAS  PubMed  Google Scholar 

  31. Stone AV, Koman LA, Callahan MF, et al. The effect of botulinum neurotoxin-A on blood flow in rats: a potential mechanism for treatment of Raynaud phenomenon. J Hand Surg [Am]. 2012;37(4):795–802.

    Article  Google Scholar 

  32. Mannava S, Plate JF, Stone AV, et al. Recent advances for the management of Raynaud phenomenon using botulinum neurotoxin A. J Hand Surg [Am]. 2011;36(10):1708–10.

    Article  Google Scholar 

  33. Neumeister MW. Botulinum toxin type A in the treatment of Raynaud’s phenomenon. J Hand Surg [Am]. 2010;35(12):2085–92.

    Article  Google Scholar 

  34. Fregene A, Ditmars D, Siddiqui A. Botulinum toxin type A: a treatment option for patients with digital ischemia in patients with Raynaud’s phenomenon. J Hand Surg [Am]. 2009;34:446–52.

    Article  Google Scholar 

  35. Flatt AE. Digital artery sympathectomy. J Hand Surg [Am]. 1980;5(6):550–6.

    Article  CAS  Google Scholar 

  36. Morgan RF, Wilgis EF. Thermal changes in a rabbit ear model after sympathectomy. J Hand Surg [Am]. 1986;11(1):120–4.

    Article  CAS  Google Scholar 

  37. Kotsis SV, Chung KC. A systematic review of the outcomes of digital sympathectomy for treatment of chronic digital ischemia. J Rheumatol. 2003;30(8):1788–92.

    PubMed  Google Scholar 

  38. Koman LA, Smith BP, Pollock Jr FE, Smith TL, Pollock D, Russell GB. The microcirculatory effects of peripheral sympathectomy. J Hand Surg [Am]. 1995;20(5):709–17.

    Article  CAS  Google Scholar 

  39. Hartzell TL, Makhni EC, Sampson C. Long-term results of periarterial sympathectomy. J Hand Surg [Am]. 2009;34(8):1454–60.

    Article  Google Scholar 

  40. Kim YH, Ng SW, Seo HS, Chang AH. Classification of Raynaud’s disease based on angiographic features. J Plast Reconstr Aesthet Surg. 2011;64(11):1503–11.

    Article  PubMed  Google Scholar 

  41. O’Brien BM, Kumar PA, Mellow CG, Oliver TV. Radical microarteriolysis in the treatment of vasospastic disorders of the hand, especially scleroderma. J Hand Surg (Br). 1992;17(4):447–52.

    Article  Google Scholar 

  42. Tomaino MM. Digital arterial occlusion in scleroderma: is there a role for digital arterial reconstruction? J Hand Surg (Br). 2000;25(6):611–3.

    Article  CAS  Google Scholar 

  43. Trocchia AM, Hammert WC. Arterial grafts for vascular reconstruction in the upper extremity. J Hand Surg [Am]. 2011;36(9):1534–6.

    Article  Google Scholar 

  44. Kryger ZB, Rawlani V, Dumanian GA. Treatment of chronic digital ischemia with direct microsurgical revascularization. J Hand Surg [Am]. 2007;32(9):1466–70.

    Article  Google Scholar 

  45. Froemel D, Fitzsimons SJ, Frank J, Sauerbier M, Meurer A, Barker JH. A review of thrombosis and antithrombotic therapy in microvascular surgery. Eur Surg Res. 2013;50(1):32–43.

    Article  CAS  PubMed  Google Scholar 

  46. Matarrese MR, Hammert WC. Revascularization of the ischemic hand with arterialization of the venous system. J Hand Surg [Am]. 2011;36(12):2047–51.

    Article  Google Scholar 

  47. Kind GM. Arterialization of the venous system of the hand. Plast Reconstr Surg. 2006;118(2):421–8.

    Article  CAS  PubMed  Google Scholar 

  48. Pederson WC, Neumeister MW. Reconstruction of the ischemic hand. Clin Plast Surg. 2011;38(4):739–50.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Centre for Musculoskeletal Research, The University of Manchester and Salford Royal NHS Foundation Trust, Stopford Building, Oxford Road, Manchester, M13 9PT, UK

    Michael Hughes MSc(Hons), MSc, MBBS & Ariane Herrick MD

  2. Hand Surgery, Salford Royal NHS Foundation Trust, Salford, Lancashire, M6 8HD, UK

    Lindsay Muir MB, MChOrth

Authors
  1. Michael Hughes MSc(Hons), MSc, MBBS
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ariane Herrick MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Lindsay Muir MB, MChOrth
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Loyola University Medical Center, Maywood, Illinois, USA

    Robert S. Dieter

  2. Northwestern Medicine Central DuPage Hospital, Glen Ellyn, Illinois, USA

    Raymond A. Dieter, Jr

  3. The University of Tennessee Medical Center, Knoxville, Tennessee, USA

    Raymond A. Dieter, III

  4. West Virginia University, Charleston, West Virginia, USA

    Aravinda Nanjundappa

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Hughes, M., Herrick, A., Muir, L. (2017). Critical Ischemia in Patients with Raynaud’s Phenomenon. In: Dieter, R., Dieter, Jr, R., Dieter, III, R., Nanjundappa, A. (eds) Critical Limb Ischemia. Springer, Cham. https://doi.org/10.1007/978-3-319-31991-9_24

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-31991-9_24

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-31989-6

  • Online ISBN: 978-3-319-31991-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation